| http://www.w3.org/ns/prov#value | - Up to now, the fact that drugs, treatments and other products in the life sciences industries have been underpinned by as few as one patent have led many to believe that there is less opportunity for the kind of patent monetisation that we have seen in areas such as mobile communications.
|
